Projects per year
Personal profile
Research interests
Dr. Jeffrey Peters’ laboratory studies the role of the peroxisome proliferator-activated receptors (PPARs). PPARs modulate gene expression through direct and indirect mechanisms. His laboratory group uses genetically modified mouse and human models, high affinity agonists, antagonists and selective, repressive ligands to delineate the roles of PPARs, with a particular interest in cancers. Through their studies, they are elucidating the molecular mechanisms by which exogenous (dietary) and endogenous (metabolic sources) lipids specifically modulate human health. They are particularly interested in delineating how natural compounds can modulate PPARs with the goal of identifying new molecules/proteins that can be targeted with existing approaches to improve the efficacy of chemoprevention and chemotherapy.
Education/Academic qualification
Post-doctoral training, Laboratory of Molecular Carcinogenesis and Laboratory of Metabolism, National Cancer Institute
1995 → 1999
Post-doctoral training, University of California
1992 → 1995
External positions
Fellow, Academy of Toxicological Sciences
Jan 1 2012 → …Fellow, Academy of Toxicological Sciences
2012 → …Fingerprint
- 8 Similar Profiles
Network
Projects
-
Unique targeting of PPAR?/? regulation for cancer prevention and therapy
Patterson, A. D., Peters, J. M., PATTERSON, A. & PETERS, J.
12/6/19 → 11/30/21
Project: Research project
-
Modulation of liver cancer by PPARbeta/delta
Peters, J. M., PETERS, J. M. & PETERS, J. M.
6/4/10 → 4/30/16
Project: Research project
-
Transcriptional regulation of polycyclic aromatic hydrocarbon metabolism
Peters, J. M. & PETERS, J. M.
1/1/10 → 11/30/14
Project: Research project
-
Modulation of AhR-dependent signaling by PPARb/d
Peters, J. M. & PETERS, J. M.
7/17/09 → 6/30/11
Project: Research project
-
Modulation of skin cancer by PPARBeta/delta
Peters, J. M. & PETERS, J.
3/1/07 → 3/31/19
Project: Research project
Research Output
-
Change is Good: What is New for ToxSci?
Peters, J. M., Jan 1 2020, In: Toxicological Sciences. 173, 1, p. 1-2 2 p.Research output: Contribution to journal › Editorial › peer-review
1 Scopus citations -
Moving forward with ToxSci
Peters, J. M., Feb 1 2020, In: Toxicological Sciences. 173, 2, p. 227-228 2 p.Research output: Contribution to journal › Editorial › peer-review
Open Access -
Perfluorooctane sulfonate alters gut microbiota-host metabolic homeostasis in mice
Zhang, L., Rimal, B., Nichols, R. G., Tian, Y., Smith, P. B., Hatzakis, E., Chang, S. C., Butenhoff, J. L., Peters, J. M. & Patterson, A. D., Feb 15 2020, In: Toxicology. 431, 152365.Research output: Contribution to journal › Article › peer-review
4 Scopus citations -
Continuing a Legacy: Adapting to Ensure the Bright Future of ToxSci
Peters, J. M., Jul 1 2019, In: Toxicological Sciences. 170, 1, p. 1-2 2 p.Research output: Contribution to journal › Editorial › peer-review
2 Scopus citations -
Interplay Between the Host, the Human Microbiome, and Drug Metabolism
Nichols, R. G., Peters, J. M. & Patterson, A. D., Jun 11 2019, In: Human genomics. 13, 1, 1 p.Research output: Contribution to journal › Review article › peer-review
Open Access12 Scopus citations
Activities
- 3 Oral presentation
-
Unraveling the controversial role of peroxisome proliferator-activated receptor-β/δ in cancer
Jeffrey Maurice Peters (Keynote speaker)
2016 → …Activity: Talk types › Oral presentation
-
Peroxisome proliferator-activated receptors as molecular targets for the treatment and prevention of diseases
Jeffrey Maurice Peters (Invited speaker)
2009 → …Activity: Talk types › Oral presentation
-
PPARβ(δ)-dependent regulation of cell proliferation, differentiation and carcinogenesis: Studies from null mouse models
Jeffrey Maurice Peters (Invited speaker)
2005 → …Activity: Talk types › Oral presentation